These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9865470)

  • 1. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of nilvadipine on rat focal cerebral ischemia.
    Li Y; Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1994; 99(1):1-6. PubMed ID: 7925784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a Ca2+ entry blocker (nilvadipine) on acute focal cerebral ischemia in rats.
    Kawamura S; Yasui N; Shirasawa M; Fukasawa H
    Exp Brain Res; 1991; 83(2):434-8. PubMed ID: 2022249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.
    Kawamura S; Shirasawa M; Fukasawa H; Yasui N
    Stroke; 1991 Jan; 22(1):51-5. PubMed ID: 1987673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ca++ antagonist and acute brain ischemia: effects of nilvadipine and nicardipine on middle cerebral artery occlusion in rats].
    Shiino A; Matsuda M; Handa J; Morikawa S; Kido C; Inubushi T; Susumu T
    Nihon Geka Hokan; 1991 Jan; 60(1):38-44. PubMed ID: 1819238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats.
    Takakura S; Susumu T; Satoh H; Mori J; Shiino A; Handa J
    Jpn J Pharmacol; 1991 Aug; 56(4):547-50. PubMed ID: 1744995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
    Takakura S; Furuichi Y; Yamamoto T; Ogawa T; Satoh H; Mori J
    Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
    Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Ca antagonist nilvadipine on stroke occurrence or recurrence and extension of asymptomatic cerebral infarction in hypertensive patients with or without history of stroke (PICA Study). 1. Design and results at enrollment.
    Shinohara Y; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Yamaguchi T; Okudera T
    Cerebrovasc Dis; 2007; 24(2-3):202-9. PubMed ID: 17596689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation.
    Yasujima M; Abe K; Kanazawa M; Yoshida K; Kohzuki M; Sato M; Takeuchi K; Omata K; Tsunoda K; Kudo K
    Tohoku J Exp Med; 1989 May; 158(1):85-94. PubMed ID: 2528846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
    Faust G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S56-61. PubMed ID: 1283191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
    Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
    Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
    Elger B; Seega J; Raschack M
    Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.